Vimarsana
Biggest News Aggregation in the World

Page 33 - Robert Langer News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Robert Langer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Robert Langer Today - Breaking & Trending Today

How microparticles could be used to deliver self-boosting vaccines - Vimarsana News

How microparticles could be used to deliver self-boosting vaccines

In this interview, we speak to Morteza Sarmadi from MIT about his labs latest research that developed microparticles able to deliver self-boosting vaccines.

Fairfield startup working on child-safe battery technology - Vimarsana News

Fairfield startup working on child-safe battery technology

Melissa Fensterstock, CEO of Landsdowne Labs, said they’re developing a battery coating...

SIGILON THERAPEUTICS : REPORTS SECOND QUARTER 2022 FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS - Form 8-K - Vimarsana News

SIGILON THERAPEUTICS : REPORTS SECOND QUARTER 2022 FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS - Form 8-K

SIGILON THERAPEUTICS REPORTS SECOND QUARTER 2022 FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS Company expects to report results of preclinical MPS-1 studies in... | August 5, 2022

'Self-Boosting' Vaccines Could Be Immunizations of the Future - Vimarsana News

'Self-Boosting' Vaccines Could Be Immunizations of the Future

MIT researchers have developed microparticles that could be used to create self-boosting vaccines, saving us time and money, and more effectively curbing the spread of germs.

Portfolio Highlights: Clinical and Financing Updates of AIxplorerBIO, Genhouse, VivaVision, Domain, Amberstone, Anji and QurAlis - Vimarsana News

Portfolio Highlights: Clinical and Financing Updates of AIxplorerBIO, Genhouse, VivaVision, Domain, Amberstone, Anji and QurAlis

/PRNewswire/ -- As the investment division of Viva Biotech, Viva BioInnovator is committed to being a collaborative platform for Innovative Biotech companies...